10.1016/j.cell.2017.09.044 Cell 162 WhiteC.YuanX.SchmidtP
Peptide therapy can be safer when prescribed and monitored by a licensed provider who screens for contraindications, rather than purchased from unregulated online sources
That said, more recent human trial data have begun to provide greater clarity regarding the translational potential of GLP-1 therapies in Alzheimers disease, helping to refine which aspects of these theoretical benefits may ultimately prove clinically meaningful
Does rapid weight loss increase gallstone risk
Additionally, a review in the Journal of Inherited Metabolic Disease (Koizumi et al., 2013) explored L-Carnitines potential in treating inborn errors of metabolism, such as fatty acid oxidation disorders and organic acidemias
Patients with significant obesity (BMI 30+) who need both weight loss and blood sugar control represent another ideal population